Viewing Study NCT01634893


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2025-12-30 @ 1:28 PM
Study NCT ID: NCT01634893
Status: COMPLETED
Last Update Posted: 2016-03-25
First Post: 2012-07-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors
Sponsor: The University of Texas Health Science Center at San Antonio
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module